Expression of the Na(+)/I(-) symporter in invasive ductal breast cancer

Folia Histochemica et Cytobiologica

Volumn 41, Issue 1, 2003, Pages 37-40

  Rudnicka, Lucyna ^a   Sińczak, Anna ^a   Szybiński, Piotr ^a   Huszno, Bogdan ^a   Stachura, Jerzy ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Breast cancer; Immunohistochemistry; Sodium iodide symporter

Indexed keywords

ANTIBODY; MEMBRANE PROTEIN; PARAFFIN; SODIUM IODIDE SYMPORTER;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST CELL; BREAST DUCT; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRON TRANSPORT; LACTATION; PROTEIN EXPRESSION; THYROID CELL; TUMOR DIFFERENTIATION;

EID: 0037279359     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cho JY, Leveille R, Kao R, Rousset B, Parlow A, Burak W, Mazzaferri E, Jhiang SM (2000) Hormonal regulation of radioiodine uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metabol 85: 2936-2943
2. Edmonds CJ, Hayes S, Kermode JC, Thompson BD (1977) Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol 50: 799-807
3. Goldman JM, Line BR, Aamodt RL, Robbins J (1980) Influence of triiodothyronine withdrawal time on I 131 uptake postthreoidectomy of thyroid cancer. J Clin Endocrinol Metab 50: 734-739
4. Heufelder AE, Morgenthaler N, Schpper ML, Joba W (2001) Sodium iodide symporter-based strategies of diagnosis and treatment of thyroidal and nonthyroidal malignancies. Thyroid 11: 839-847
5. Kaminsky SM, Levy O, Salvador C, Dai G, Carrascp N (1994) Na+/I-symporter activity is present in membrane vesicles from thyrotropin-deprived non I-transporting cultured thyroid cells. Proc Natl Acad Sci USA 91: 3789-3793
6. Kilbane MT, Ajjan RA, Weetman AP, Dwyer R, McDermott EW, O'Higgins NJ, Smyth PP (2000) Tissue iodine content and serum mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metabol 85: 1245-1250
7. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA (2000) Retinoic acid induces sodium/iodide symporter gene expression and ratio-uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA 97: 8519-8524
8. Nakamoto Y, Saga T, Misaki T, Kobayashi H, Sato N, Ishimori T, Kosugi S, Sakahara H, Konishi J (2000) Establishment and characterization of the breast cancer cell line expressing Na+I-symporter for radioiodide concentrator gene therapy. J Nucl Med 41: 1898-1904
9. Paire A, Biernier-Valentin F, Selmi-Ruby S, Russet B (1997) Characterization of the rat thyroid iodine transporter using antipeptide antibodies. J Biol Chem 272: 18245-18249
10. Piri L, David A (2000) Taking up iodide in breast tissue. Nature 406: 688-689
11. Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T (1997) Increased expression of the Na+/I-symporter in cultured human thyroid cells exposed to thyrotropin and in Grave's thyroid tissue. J Clin Endocrinol Metab 82: 3331-3336
12. Simon D, Koehrle J, Schmutzler C, Mainz K, Reiners C, Roeher HD (1996) Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basic and first clinical results. Exp Clin Endocrinol Diabetes 104: 13-15
13. Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM (1997) Expression, exon-intron organization and chromosome mapping of human sodium iodine symporter. Endocrinology 138: 3555-3558
14. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N (2000) The mammary gland iodine transporter is expressed during lactation and in breast cancer. Nat Med 8: 871-878